BSEN-760

N/A

Report date: 2024/02/23 12:03:14

NME

Base Information

Drug NameBSEN-760

Drug Alias NameBSEN-760BSEN760

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionVoltage-gated potassium channel subunit Kv7.2 activatorsPotassium voltage-gated channel subfamily KQT member 3 activatorsTransient receptor potential cation channel subfamily V member 1 inhibitors

TargetsVoltage-gated potassium channel subunit Kv7.2Potassium voltage-gated channel subfamily KQT member 3Transient receptor potential cation channel subfamily V member 1

Therapy Area/IndicationsChronic Pain

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryIsrael

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesBsense Bio Therapeutics Ltd

China Registration ClassN/A

Develop Information

Active CompaniesBsense Bio Therapeutics Ltd

Inactive CompaniesN/A

Active IndicationsChronic Pain

Inactive IndicationsN/A

Other Information

ATC CodeN/A